Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types

BACKGROUND: Few data exist on differences in treatment effectiveness and safety in atopic dermatitis patients of different skin types. OBJECTIVE: To investigate treatment outcomes of dupilumab, methotrexate, and ciclosporin, and morphological phenotypes in atopic dermatitis patients, stratified by F...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosma, Angela L., Ouwerkerk, Wouter, Heidema, Madeline J., Prieto-Merino, David, Ardern-Jones, Michael R., Beattie, Paula, Brown, Sara J., Ingram, John R., Irvine, Alan D., Ogg, Graham, Patel, Prakash, Reynolds, Nick J., Hearn, R.M. Ross, Wan, Mandy, Warren, Richard B., Woolf, Richard T., Hyseni, Ariënna M., Gerbens, Louise A.A., Spuls, Phyllis I., Flohr, Carsten, Middelkamp-Hup, Maritza A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661502/
https://www.ncbi.nlm.nih.gov/pubmed/36387062
http://dx.doi.org/10.1016/j.jdin.2022.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661502/
https://www.ncbi.nlm.nih.gov/pubmed/36387062
http://dx.doi.org/10.1016/j.jdin.2022.09.006

Ejemplares similares